Get the Stockscreener App
0.5329
0.23%
0.0022
Cosmos Health Inc stock is traded at $0.5329, with a volume of 369.91K.
It is up +0.23% in the last 24 hours and up +15.23% over the past month.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
See More
Previous Close:
$0.5307
Open:
$0.5307
24h Volume:
369.91K
Relative Volume:
0.51
Market Cap:
$19.88M
Revenue:
$53.55M
Net Income/Loss:
$-15.13M
P/E Ratio:
-0.4934
EPS:
-1.08
Net Cash Flow:
$-23.86M
1W Performance:
+5.62%
1M Performance:
+15.23%
6M Performance:
+25.45%
1Y Performance:
-24.01%
1-Day Range:
$0.52
$0.56
1-Week Range:
$0.4799
$0.56
52-Week Range:
$0.2801
$1.32
Cosmos Health Inc Stock (COSM) Company Profile
Name
Cosmos Health Inc
Sector
Industry
Phone
312-536-3102
Address
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
Compare COSM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COSM
Cosmos Health Inc
|
0.5324 | 19.82M | 53.55M | -15.13M | -23.86M | -1.08 |
|
MCK
Mckesson Corporation
|
827.53 | 101.82B | 387.09B | 4.23B | 6.01B | 32.12 |
|
COR
Cencora Inc
|
347.01 | 66.14B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
CAH
Cardinal Health Inc
|
208.08 | 48.81B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
HSIC
Henry Schein Inc
|
78.59 | 9.25B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.35 | 818.31M | 2.22M | -5.63M | -1.68M | -0.24 |
Cosmos Health Inc Stock (COSM) Latest News
Cosmos Health’s Wild Ride: Can COSM Survive Its Own Volatility? - AD HOC NEWS
Cosmos Health (COSM) Subsidiary to Manufacture PathMuscle for Li - GuruFocus
Cosmos Health Inc. Subsidiary Cana Laboratories Enters Manufacturing Agreement for PathMuscle with Libytec Pharmaceutical in Greece - Quiver Quantitative
Cosmos Health to manufacture PathMuscle drug for Greek distributor - Investing.com
Cosmos Health to manufacture PathMuscle drug for Greek distributor By Investing.com - Investing.com Canada
Cosmos Health Enters Manufacturing Agreement with Libytec - GlobeNewswire
New muscle spasm medicine expected to top 1.2M doses in Greece - Stock Titan
Cosmos Health stock rises on manufacturing deal with Libytec By Investing.com - Investing.com UK
Cosmos Health stock rises on manufacturing deal with Libytec - Investing.com
Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy - ACCESS Newswire
How one healthcare supplier is remaking its business to dodge tariffs - Stock Titan
Cosmos Health receives Nasdaq non-compliance bid price notice - MSN
Siokas buys Cosmos Health (COSM) shares worth $43,000 By Investing.com - Investing.com Australia
Siokas buys Cosmos Health (COSM) shares worth $43,000 - Investing.com India
Cosmos Health CEO Acquires Shares Through Debt Exchange - TradingView — Track All Markets
Will Cosmos Health Inc. (V67A) stock benefit from mergers2025 Macro Impact & Weekly Return Optimization Plans - Улправда
Is Cosmos Health Inc. stock a safe haven assetPortfolio Risk Summary & Detailed Earnings Play Strategies - Улправда
Can Cosmos Health Inc. (V67A) stock stage a strong rebound this quarterMarket Trend Review & AI Forecast Swing Trade Picks - Улправда
Can Cosmos Health Inc. stock resist sector downturnsJuly 2025 Recap & Daily Profit Focused Screening - Улправда
Is Cosmos Health Inc. (V67A) stock in buy zone after pullback2025 Market WrapUp & Weekly High Conviction Trade Ideas - Улправда
Cosmos Health is Forcing the Market to Reframe the Conversation - ACCESS Newswire
Will Cosmos Health Inc. stock deliver strong dividend growthWeekly Trade Recap & Verified Entry Point Detection - Улправда
Can Cosmos Health Inc. stock surprise with earnings upsideMarket Growth Report & High Accuracy Investment Signals - DonanımHaber
Aug Catalysts: How dovish Fed policy supports Cosmos Health Inc. (V67A) stock2025 Stock Rankings & Weekly High Potential Stock Alerts - Улправда
Aug Outlook: Will Cosmos Health Inc. stock return to pre crisis levelsJuly 2025 Big Picture & AI Optimized Trading Strategy Guides - Улправда
Is Cosmos Health Inc. stock a defensive play in 2025Trade Ideas & Low Volatility Stock Suggestions - Улправда
Analyst Downgrade: Will Cosmos Health Inc. (V67A) stock benefit from mergersMarket Sentiment Summary & Stock Timing and Entry Methods - Улправда
Can Cosmos Health Inc. (V67A) stock expand revenue streamsMarket Growth Report & Capital Protection Trade Alerts - Улправда
Cosmos Health receives Nasdaq notice for minimum bid price deficiency By Investing.com - Investing.com Canada
Cosmos Health Receives Nasdaq Non-Compliance Bid Price Notice - TipRanks
Cosmos Health receives Nasdaq notice for minimum bid price deficiency - Investing.com
Cosmos Health Received Notice of Noncompliance - TradingView — Track All Markets
[8-K] Cosmos Health Inc. Reports Material Event | COSM SEC FilingForm 8-K - Stock Titan
Market Wrap: How dovish Fed policy supports Cosmos Health Inc. (V67A) stock2025 Bull vs Bear & High Accuracy Investment Signals - Улправда
Cosmos Health CEO Converts Debt to Equity - TradingView — Track All Markets
Chmn Siokas Buys 168,472 ($70K) Of Cosmos Health Inc [COSM] - TradingView — Track All Markets
Weekly Recap: Is Cosmos Health Inc stock a buy on dips2025 Risk Factors & Low Drawdown Investment Ideas - moha.gov.vn
Cosmos Health Tries To Shake Off Losses With Record Sales - Finimize
How Cosmos Health Inc. stock compares to growth peersProfit Target & Verified Stock Trade Ideas - Newser
Published on: 2025-12-05 04:07:02 - Newser
Can Cosmos Health Inc. (V67A) stock sustain revenue momentumJuly 2025 Catalysts & Reliable Entry Point Trade Alerts - Newser
Is Cosmos Health Inc. (V67A) stock expanding market penetrationJuly 2025 Technicals & Fast Exit Strategy with Risk Control - Newser
Cosmos Health enters long-term partnership with Prime Ledger - MSN
Cosmos Health Launches Strategic Partnership With Prime Ledger to Transform $300M Treasury and Tokenize IP Assets - The Manila Times
Cosmos Health partners with Prime Ledger for digital transformation - Investing.com
Cosmos Health partners with Prime Ledger for digital transformation By Investing.com - Investing.com South Africa
Cosmos Health Inc Stock (COSM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cosmos Health Inc Stock (COSM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Siokas Grigorios | Chief Executive Officer |
Dec 15 '25 |
Buy |
0.42 |
168,472 |
70,000 |
6,628,457 |
| Siokas Grigorios | Chief Executive Officer |
Nov 28 '25 |
Buy |
0.64 |
76,360 |
49,000 |
6,459,985 |
| Siokas Grigorios | Chief Executive Officer |
Nov 25 '25 |
Buy |
0.63 |
55,732 |
35,000 |
6,383,625 |
| Siokas Grigorios | Chief Executive Officer |
Nov 21 '25 |
Buy |
0.68 |
56,080 |
38,000 |
6,327,893 |
| Siokas Grigorios | Chief Executive Officer |
Nov 20 '25 |
Buy |
0.62 |
51,315 |
32,000 |
6,271,813 |
| Siokas Grigorios | Chief Executive Officer |
Nov 19 '25 |
Buy |
0.65 |
61,614 |
40,000 |
6,220,498 |
| Siokas Grigorios | Chief Executive Officer |
May 23 '25 |
Buy |
0.45 |
34,004 |
15,217 |
6,158,884 |
| Siokas Grigorios | Chief Executive Officer |
May 22 '25 |
Buy |
0.44 |
141,825 |
62,800 |
6,124,880 |
| Siokas Grigorios | Chief Executive Officer |
May 21 '25 |
Buy |
0.47 |
174,172 |
82,000 |
5,983,055 |
| Siokas Grigorios | Chief Executive Officer |
May 20 '25 |
Buy |
0.45 |
147,563 |
65,961 |
5,808,883 |
0.00%
82.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):